精神藥理學
心理学 |
---|
![]() |
心理藥物學(英文:Psychopharmacology )是指以科學方法研究預備、使用心理疾病藥物及這些藥物的效用。心理疾病相關藥物稱為psychotropic medications(psycho:心理的;tropic:作用於)。
基本概念
[编辑]- 生物利用度 :(bioavailability)真正身體最終吸收了所用的藥
- 給藥途徑:決定藥物進入血管的速度及完整度
- 電離 (ionisation):非游離形式的藥物因不帶電荷而易滲入細胞膜[8],受住血管或消化系統等體內pH值,及藥物自己的酸度係數(pKa值)影響[9]
- 血漿蛋白結合 (binding):藥物困住在血漿、肌肉或脂肪中而變動不活躍,令到藥物在目標位置濃度降低而效用減少。或者多種藥物同時服用時,藥物甲導致藥物乙濃度太高而藥物過量。
- 生物轉化作用
- 速率方程:例如酒精是zero-order kinetics,即不論飲用多少酒,身體每個小時只能處理最多15毫升的酒精[12]。對應first-order kinetics,藥物濃度越高則消化速度越快。
- 排泄作用,透過不同方法將藥物離開身體,如製造母乳、呼吸、出汗、排尿等。
親和性 (Affinity) | 效能(Efficacy) | |
---|---|---|
活化劑(agonist) | 高 | 高 |
阻斷劑(antagonist) | 中至高 | 低 |
- 構象改變,當受體和配體結合就會令蛋白發生結構上改變,從而影響效能
- 調升與調降:指因為配體的數量影響(太多或太少),受體的數量或敏感程度改變[15][16]
- 劑量反應曲線[17]:
指不同劑量下的反應。低劑量亦可代表只有少量配體佔用了[18]。若要0.25單位反應, 藥B有更高的potent。但若要0.75單位反應藥A反而更potent。
化學訊號
[编辑]精神作用藥物通常用神經遞質來影響神經傳導。神經遞質主要一種化學物質來讓神經元互相溝通,而精神作用藥物則影響這個溝通過程。這些藥物可以
- 作為神經遞質的前體(precursor)(作為製造神經遞質的原材料)
- 壓抑神經遞質的生成
- 避免突触小泡(presynaptic vesicle)儲存神經遞質
- 刺激或抑制神經遞質釋出
- 刺激或抑制後突觸(post-synaptic)的受體運作(Receptor)
- 刺激再攝取泵(autoreceptor),減少神經遞質釋出
- 阻礙再攝取泵(autoreceptor),增加神經遞質釋出
- 壓抑神經傳導 breakdown
- 阻礙前突觸(presynaptic)被再吸收(reuptake)
The other central method through which drugs act is by affecting communications between cells through hormones. Neurotransmitters can usually only travel a microscopic distance before reaching their target at the other side of the synaptic cleft, while hormones can travel long distances before reaching target cells anywhere in the body. Thus, the endocrine system is a critical focus of psychopharmacology because 1) drugs can alter the secretion of many hormones; 2) hormones may alter the behavioral responses to drugs; 3) hormones themselves sometimes have psychoactive properties; and 4) the secretion of some hormones, especially those dependent on the pituitary gland, is controlled by neurotransmitter systems in the brain.
常見心理藥物
[编辑]相關期刊
[编辑]- Experimental and Clinical Psychopharmacology (页面存档备份,存于互联网档案馆), American Psychological Association
- Journal of Clinical Psychopharmacology, Lippincott Williams & Wilkins
- Journal of Psychopharmacology, British Association for Psychopharmacology, SAGE Publications
- Psychopharmacology, Springer Berlin/Heidelberg
- Neuropsychopharmacology, Nature Publishing Group
參考來源
[编辑]- ^ L., Hart, Carl. Drugs, society & human behavior 15th ed. New York, NY: McGraw-Hill. 2013. ISBN 9780073529745. OCLC 808107397.
- ^ editor., Kandel, Eric R. Mack, Sarah, art. Principles of neural science. [2019-03-21]. ISBN 9780071390118. OCLC 918899790. (原始内容存档于2021-03-23).
- ^ Greengard, P. The neurobiology of slow synaptic transmission. Science (New York, N.Y.). 2001-11-02, 294 (5544): 1024–1030 [2019-03-21]. ISSN 0036-8075. PMID 11691979. doi:10.1126/science.294.5544.1024. (原始内容存档于2019-03-22).
- ^ CDC. Disease of the Week - Alcohol and Pregnancy. Centers for Disease Control and Prevention. 2017-09-06 [2019-03-21]. (原始内容存档于2019-03-21) (美国英语).
- ^ 4. Principles of Psychopharmacology for Mental Health Professionals. Hoboken, NJ, USA: John Wiley & Sons, Inc. 2005-10-07: 9–35. ISBN 9780471794639.
- ^ 保安局禁毒處 - 戒毒治療和康復服務戒毒治療和康復服務. www.nd.gov.hk. [2019-03-21]. (原始内容存档于2018-11-18).
- ^ 7.0 7.1 1947-, Meyer, Jerrold S.,; A.,, Rice, Susan; R.,, Yates, Jennifer. 2,3. Psychopharmacology : drugs, the brain, and behavior Second edition. Sunderland, Massachusetts. ISBN 087893510X. OCLC 819641635.
- ^ Wesley McCammon, Fluid Mosaic Model of the Cell Membrane, 2009-07-19 [2019-03-21], (原始内容存档于2020-02-24)
- ^ Khutoryanskiy, Vitaliy V. Longer and safer gastric residence. Nature Materials. 2015-10, 14 (10): 963–964. ISSN 1476-1122. doi:10.1038/nmat4432.
- ^ Carbon Oxidation. learn.genetics.utah.edu. [2019-03-21]. (原始内容存档于2019-03-21).
- ^ Nucleus Medical Media, Biology: Cell Structure I Nucleus Medical Media, 2015-03-18 [2019-03-21], (原始内容存档于2019-06-02)
- ^ What Is A Standard Drink? | National Institute on Alcohol Abuse and Alcoholism (NIAAA). www.niaaa.nih.gov. [2019-03-19]. (原始内容存档于2019-03-26).
- ^ Sinauer Associates, Inc., Publishers. www.sinauer.com. [2019-03-19]. (原始内容存档于2019-03-20).
- ^ Purple Haze of Parkinson’s: How Dopamine Works. Journey with Parkinson's. 2015-08-05 [2019-03-19]. (原始内容存档于2019-09-29) (英语).
- ^ 2. General Mechanisms of the Endocrine Regulation • Functions of Cells and Human Body. [2019-03-21]. (原始内容存档于2019-03-21) (美国英语).
- ^ About Huntington's Disease and Serotonin. HOPES Huntington's Disease Information. 2011-06-30 [2019-03-21]. (原始内容存档于2019-03-14) (美国英语).
- ^ Pharmapedia, Agonist Dose Response Curves, 2015-06-11 [2019-03-21], (原始内容存档于2021-05-21)
- ^ basic_principles_of_pharm [TUSOM | Pharmwiki]. tmedweb.tulane.edu. [2019-03-21]. (原始内容存档于2019-03-21) (英语).
- ^ ToxTutor - Determining the Safety of a Drug. toxtutor.nlm.nih.gov. [2019-03-21]. (原始内容存档于2019-03-21).
- ^ Pharmapedia, Efficacy vs Potency, 2015-06-15 [2019-03-19], (原始内容存档于2022-02-25)
- ^ W,, Kalat, James. Biological psychology 12 e. Australia. : 49–57. ISBN 9781305105409. OCLC 898154491.
|